https://www.prnewswire.com/news-releases/synlogic-announces-synthetic-biotic-for-gout-developed-in-partnership-with-ginkgo-bioworks-301603915.html
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through...
in partnership with
https://www.macrotrends.net/stocks/charts/SYBX/synlogic/quick-ratio
Synlogic Quick Ratio 2013-2026 | SYBX | MacroTrends
Historical quick ratio values for Synlogic (SYBX) over the last 10 years.
quick ratiosynlogic20132026macrotrends
https://www.sofi.com/invest/stock/SYBX/
Buy Synlogic Stock - SYBX Stock Price, Quote & News | SoFi
See real time price charts for SYBX stock, historical data, and recent news. Buy SYBX stock online with no commission fees.
price quotebuysynlogicstocknews
https://www.biospace.com/synlogic-progresses-clinical-and-preclinical-pipeline-and-outlines-2018-catalysts
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts - BioSpace
Jan 5, 2018 - Synlogic today provided an overview of recent progress and outlined key objectives and anticipated milestones for 2018.
synlogicprogressesclinicalpipelineoutlines
https://www.prnewswire.com/news-releases/joint-team-from-mit-and-synlogic-named-a-biotechnology-grand-challenge-winner-by-air-force-research-laboratory-301219762.html?tc=eml_cleartime
Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research...
/PRNewswire/ -- A collaboration between MIT Voigt Lab and Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of...
https://www.biospace.com/synlogic-announces-first-industry-collaboration-to-develop-a-new-class-of-medicines-designed-to-power-the-microbiome
Synlogic Announces First Industry Collaboration To Develop A New Class Of Medicines Designed To...
https://www.synlogictx.com/
Synlogic Therapeutics
Dec 17, 2025 - Synlogic is the leading company advancing therapeutics based on synthetic biology, working at the intersection of biology and engineering to treat disease.
synlogictherapeutics